EI
EtiraRX, Inc.
SEC filingBiotechnology · Dallas, TX
Amount raised$2.3Msold at filing
Total offering$3M$722K still open
Investors in the raise21count reported to the SEC
FiledMay 14, 2026first sale Apr 17, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Annalisa JenkinsDirector
Russell HaywardExecutive Officer, Director
Ganesh RajExecutive Officer, Director
Justin StebbingDirector
Executive officers, directors and promoters as listed on the Form D.